A method, apparatus, and system are provided for the printing and maturation of living tissue in an Earth-referenced reduced gravity environment such as that found on a spacecraft or on other celestial bodies. The printing may be three-dimensional structures. The printed structures may be manufactured from low viscosity biomaterials.

A device for providing a sterile environment for the incubation of cell cultures is proposed, comprising a warming chamber with heating elements, sensors for temperature, humidity and CO2, and a gas supply providing a gas connection in the interior. The device also has a cultivation tank located in the warming chamber. This has a sealable passage for each sensor, and also a sealable gas inlet and outlet that couples to the gas connection inside the warming chamber. The sensors of the warming chamber are arranged to fit into respective passages of the cultivation vessel. The device also has a water reservoir arranged in the cultivation tank. The three elements of the warming chamber, the cultivation container and the water reservoir can be sterilized separately using the optimal method for each. Since the sensors are not part of the cultivation container, the latter can also be decontaminated by high temperatures. The sterilized warming chamber ensures that the cell cultures in the cultivation container cannot be contaminated from the outside, nor can they cause contamination in the laboratory.

A cell culturing system configured to move a liquid sample from a cell culturing device to a sampling channel via a sample introduction channel. The sampling device includes a sampling channel having a main-mechanism-side pump disposed between a cleaning solution storage unit and the sample introduction channel and is configured to allow a cleaning solution to flow to a detection unit. The sample introduction channel includes an introduction-mechanism-side pump that is configured to allow the sample to flow from the sample introduction channel to the detection unit.

Methods of production of edible filamentous fungal biomat formulations are provided as standalone protein sources and/or protein ingredients in foodstuffs as well as a one-time use or repeated use self-contained biofilm-biomat reactor comprising a container with at least one compartment and placed within the compartment(s), a feedstock, a fungal inoculum, a gas-permeable membrane, and optionally a liquid nutrient medium.

Some embodiments are directed to an apparatus for forming discrete biomass receptacles from a base material that is created via cultivating or processing algae for biofuel production. The apparatus includes a supplier to supply heat softened biomaterial; a rotatable molder to receive the heat softened biomaterial that includes a heated hollow mold; a rotator configured to rotate the rotatable molder; and a controller configured to control the rotator to rotate the heated hollow mold such that the heat softened biomaterial disperses and adheres to walls of the heated hollow mold, the controller also being configured to control the rotator to continue rotating the heated hollow mold as the heat softened biomaterial cools so as to impede sagging and deformation of the biomass receptables being formed, such that the receptacles that are formed are configured to house algae via at least one of the cultivating and processing of the algae.

A packed bed bioreactor is fabricated as a monolith entirely using additive manufacturing techniques, also known as 3D printing. Construction of a bioreactor in this manner enables control over the reactor dimensions and properties (such as void volume) as well as the dimensions, shape, and pattern of the media bed. Together these attributes give the end-user control over the size, shape, material, and flow characteristics of the bioreactor.

Cartridge for manufacturing a population of cells suitable for formulation as a cellular therapeutic are disclosed herein, along with systems for operating the cartridges and performing methods to generate the population of cells suitable for formulation as a cellular therapeutic. The population of cells suitable for formulation as a cellular therapeutic can be T-cells, including CAR T-cells. The systems and methods can be largely automated.

Methods of production of edible filamentous fungal biomat formulations are provided as standalone protein sources and/or protein ingredients in foodstuffs as well as a one-time use or repeated use self-contained biofilm-biomat reactor comprising a container with at least one compartment and placed within the compartment(s), a feedstock, a fungal inoculum, a gas-permeable membrane, and optionally a liquid nutrient medium.

Methods of production of edible filamentous fungal biomat formulations are provided as standalone protein sources and/or protein ingredients in foodstuffs as well as a one-time use or repeated use self-contained biofilm-biomat reactor comprising a container with at least one compartment and placed within the compartment(s), a feedstock, a fungal inoculum, a gas-permeable membrane, and optionally a liquid nutrient medium.

An assembly for delivering a fluid includes a fluid dispenser connected to a fluid supply conduit. The fluid dispenser includes a fluid outlet positioned along a length of the fluid dispenser. The fluid outlet is configured to deliver the fluid from the fluid supply conduit at a flow rate that varies along the length of the fluid dispenser.